UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

: SoluCortef100mgpulvervatskainj-SE-PLC-PPD02 - XML Representation

Raw xml | Download



<PackagedProductDefinition xmlns="http://hl7.org/fhir">
  <id value="SoluCortef100mgpulvervatskainj-SE-PLC-PPD02"/>
  <meta>
    <profile
             value="http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition SoluCortef100mgpulvervatskainj-SE-PLC-PPD02</b></p><a name="SoluCortef100mgpulvervatskainj-SE-PLC-PPD02"> </a><a name="hcSoluCortef100mgpulvervatskainj-SE-PLC-PPD02"> </a><a name="hcSoluCortef100mgpulvervatskainj-SE-PLC-PPD02-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-SoluCortef100mgpulvervatskainj-SE-PLC-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001390-00005561,http://ema.europa.eu/fhir/eurdId#10855; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Powder and solvent for solution for injection; indication = Substitutionsbehandling:  Vid primär och sekundär binjurebarkinsufficiens och kongenitalt adrenogenitalt syndrom när oral terapi inte kan genomföras, t ex vid akuta sjukdomstillstånd. I samband med operativa ingrepp när glukokortikoidreserven är otillräcklig.   Ospecifik terapi: T ex vid chock av olika genes som komplement till annan behandling, anafylaktiska reaktioner, svåra allergiska tillstånd och reaktioner efter insekts- och ormbett samt astma.   Vid SLE, kongenital binjurebarkhyperplasi, leukemi och malignt lymfom.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = hydrocortisone</a></p><p><b>containedItemQuantity</b>: 25 Cartridge<span style="background: LightGoldenRodYellow"> (Details: 200000000014  code200000002114 = '200000002114')</span></p><p><b>description</b>: </p><div><p>Flaska, 25 x (100 mg + 2 ml) (Act-O-Vial)</p>
</div><h3>MarketingStatuses</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003529}">Cardboard</span></p><blockquote><p><b>containedItem</b></p><h3>Items</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Reference</b></td></tr><tr><td style="display: none">*</td><td><a href="ManufacturedItemDefinition-SoluCortef100mgpulvervatskainj-SE-PLC-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Powder for solution for injection; unitOfPresentation = Cartridge</a></td></tr></table><p><b>amount</b>: 25 Cartridge<span style="background: LightGoldenRodYellow"> (Details: 100000110633~200000000014  code200000002114 = '200000002114')</span></p></blockquote></blockquote></div>
  </text>
  <identifier>
    <system value="http://ema.europa.eu/example/pcid"/>
  </identifier>
  <packageFor>🔗 
    <reference
               value="MedicinalProductDefinition/SoluCortef100mgpulvervatskainj-SE-PLC-MPD"/>
  </packageFor>
  <containedItemQuantity>
    <value value="25"/>
    <unit value="Cartridge"/>
    <system value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
    <code value="200000002114"/>
  </containedItemQuantity>
  <description value="Flaska, 25 x (100 mg + 2 ml) (Act-O-Vial)"/>
  <marketingStatus>
    <country>
      <coding>
        <system value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
        <code value="100000000535"/>
        <display value="Kingdom of Sweden"/>
      </coding>
    </country>
    <status>
      <coding>
        <system value="https://spor.ema.europa.eu/v1/lists/100000072052"/>
        <code value="100000072083"/>
        <display value="Marketed"/>
      </coding>
    </status>
  </marketingStatus>
  <packaging>
    <type>
      <coding>
        <system value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
        <code value="100000073498"/>
        <display value="Box"/>
      </coding>
    </type>
    <quantity value="1"/>
    <material>
      <coding>
        <system value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
        <code value="200000003529"/>
        <display value="Cardboard"/>
      </coding>
    </material>
    <containedItem>
      <item>
        <reference>🔗 
          <reference
                     value="ManufacturedItemDefinition/SoluCortef100mgpulvervatskainj-SE-PLC-MID"/>
        </reference>
      </item>
      <amount>
        <value value="25"/>
        <unit value="Cartridge"/>
        <system
                value="http://spor.ema.europa.eu/v1/lists/100000110633~200000000014"/>
        <code value="200000002114"/>
      </amount>
    </containedItem>
  </packaging>
</PackagedProductDefinition>